Investing.com - GlaxoSmithKline ADR reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
GlaxoSmithKline ADR announced earnings per share of £0.7802 on revenue of £11.23B. Analysts polled by Investing.com anticipated EPS of £0.5471 on revenue of £10.49B.
GlaxoSmithKline ADR shares are up 7.31% from the beginning of the year and are trading at £39.49 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% from the start of the year.
GlaxoSmithKline ADR shares lost 0.08% in intra-day trade the report.
GlaxoSmithKline ADR follows other major Healthcare sector earnings this month
GlaxoSmithKline ADR's report follows an earnings beat by J&J on July 21, who reported EPS of £2.48 on revenue of £23.31B, compared to forecasts EPS of £2.29 on revenue of £22.49B.
UnitedHealth had beat expectations on July 15 with second quarter EPS of £4.7 on revenue of £71.32B, compared to forecast for EPS of £4.43 on revenue of £69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar